CALCITRIOL

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C27H44O3
Molecular Weight	416.6375
Optical Activity	UNSPECIFIED
Defined Stereocenters	6 / 6
E/Z Centers	2
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

C[C@]([H])(CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])/C(=C(\[H])/C(/[H])=C\3/C[C@]([H])(C[C@@]([H])(C3=C)O)O)/CCC[C@]12C

InChI

InChIKey=GMRQFYUYWCNGIN-NKMMMXOESA-N

InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,23-,24+,25+,27-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C27H44O3
Molecular Weight	416.6375
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	6 / 6
E/Z Centers	2
Optical Activity	UNSPECIFIED

Description
Sources: https://www.ncbi.nlm.nih.gov/mesh/68002117 | https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/021068a_phrmr_P1.pdfhttp://www.accessdata.fda.gov/drugsatfda_docs/label/1998/21068lbl.pdf
Curator's Comment:: description was created based on several sources, including: https://www.drugs.com/cdi/calcitriol.html http://www.wikidoc.org/index.php/Calcitriol_(oral)

Calcitriol is vitamin D3. Vitamin D is important for the absorption of calcium from the stomach and for the functioning of calcium in the body. Calcitriol is used to treat hyperparathyroidism (overactive parathyroid glands) and metabolic bone disease in people who have chronic kidney failure and are not receiving dialysis. Calcitriol is also used to treat calcium deficiency (hypocalcemia). The early signs and symptoms of vitamin D intoxication associated with hypercalcemia include: weakness, headache, somnolence, nausea, vomiting, dry mouth, constipation, muscle pain, bone pain and metallic taste. Cholestyramine has been reported to reduce intestinal absorption of fatsoluble vitamins; as such it may impair intestinal absorption of Calcitriol. Ketoconazole may inhibit both synthetic and catabolic enzymes of calcitriol.

CNS Activity

Originator

Approval Year

Targets

Primary Target	Pharmacology	Potency
Vitamin D3 receptor 8 Target ID: P11473 Gene ID: 7421.0 Gene Symbol: VDR Target Organism: Homo sapiens (Human) Sources: http://www.drugbank.ca/drugs/DB00136 \| https://www.ncbi.nlm.nih.gov/pubmed/10517670	Binding Agent 996	0.22 nM [Kd]
Cytochrome P450 24A1 5 Target ID: CHEMBL4521 Sources: http://www.drugbank.ca/drugs/DB00136 \| https://www.ncbi.nlm.nih.gov/pubmed/16207822 Ahn, J. et al. (2016) 'Vitamin D Hormone', p.327 Retrieved from \| https://books.google.ru/books?id=-OSECgAAQBAJ	Substrate 609
Cytochrome P450 3A4 116 Target ID: CHEMBL340 Sources: http://www.drugbank.ca/drugs/DB00136 \| https://www.ncbi.nlm.nih.gov/pubmed/16207822	Substrate 609

Conditions

Condition	Modality	Highest Phase	Product
Unknown 2502
Secondary hyperparathyroidism 8 Sources: http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/21068lbl.pdf	Primary	Approved 8043	ROCALTROL Approved Use Predialysis Patients Calcitriol Capsules are indicated in the management of secondary hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (Ccr 15 to 55 mL/min) not yet on dialysis. In children, the creatinine clearance value must be corrected for a surface area of 1.73 square meters. A serum iPTH level of ≥100 pg/mL is strongly suggestive of secondary hyperparathyroidism. Dialysis Patients Calcitriol Capsules are indicated in the management of hypocalcemia and the resultant metabolic bone disease in patients undergoing chronic renal dialysis. In these patients, calcitriol administration enhances calcium absorption, reduces serum alkaline phosphatase levels, and may reduce elevated parathyroid hormone levels and the histological manifestations of osteitis fibrosa cystica and defective mineralization. Hypoparathyroidism Patients Calcitriol Capsules are also indicated in the management of hypocalcemia and its clinical manifestations in patients with postsurgical hypoparathyroidism, idiopathic hypoparathyroidism, and pseudohypoparathyroidism. Launch Date 2.72159998E11
Hypocalcemia 92 Sources: http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/21068lbl.pdf	Preventing	Approved 8043	ROCALTROL Approved Use Predialysis Patients Calcitriol Capsules are indicated in the management of secondary hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (Ccr 15 to 55 mL/min) not yet on dialysis. In children, the creatinine clearance value must be corrected for a surface area of 1.73 square meters. A serum iPTH level of ≥100 pg/mL is strongly suggestive of secondary hyperparathyroidism. Dialysis Patients Calcitriol Capsules are indicated in the management of hypocalcemia and the resultant metabolic bone disease in patients undergoing chronic renal dialysis. In these patients, calcitriol administration enhances calcium absorption, reduces serum alkaline phosphatase levels, and may reduce elevated parathyroid hormone levels and the histological manifestations of osteitis fibrosa cystica and defective mineralization. Hypoparathyroidism Patients Calcitriol Capsules are also indicated in the management of hypocalcemia and its clinical manifestations in patients with postsurgical hypoparathyroidism, idiopathic hypoparathyroidism, and pseudohypoparathyroidism. Launch Date 2.72159998E11
Mild to moderate plaque psoriasis 3 Sources: http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022087lbl.pdf	Primary	Approved 8043	VECTICAL Approved Use VECTICAL Ointment is indicated for the topical treatment of mild to moderate plaque psoriasis in adults 18 years and older. Launch Date 2.72159998E11

C_max

Value	Dose	Co-administered	Analyte	Population
1100 pg/mL EXPERIMENT https://www.ncbi.nlm.nih.gov/pubmed/12496746	38 μg 3 times / week multiple, oral dose: 38 μg route of administration: Oral experiment type: MULTIPLE co-administered: PACLITAXEL	PACLITAXEL	CALCITRIOL plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN
73.1799999999999 pg/mL Clinical Trial https://clinicaltrials.gov/ct2/show/NCT00419666	3 ug/g 2 times / day multiple, topical dose: 3 ug/g route of administration: topical experiment type: multiple co-administered:		CALCITRIOL plasma	Homo sapiens population: unhealthy age: Adolescents sex: F+M food status:
75.74 pg/mL Clinical Trial https://clinicaltrials.gov/ct2/show/NCT00419666	3 ug/g single, topical dose: 3 ug/g route of administration: topical experiment type: single co-administered:		CALCITRIOL plasma	Homo sapiens population: unhealthy age: Adolescents sex: F+M food status:

AUC

Value	Dose	Co-administered	Analyte	Population
8100 pg × h/mL EXPERIMENT https://www.ncbi.nlm.nih.gov/pubmed/12496746	38 μg 3 times / week multiple, oral dose: 38 μg route of administration: Oral experiment type: MULTIPLE co-administered: PACLITAXEL	PACLITAXEL	CALCITRIOL plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN
737.74 pg*h/mL Clinical Trial https://clinicaltrials.gov/ct2/show/NCT00419666	3 ug/g 2 times / day multiple, topical dose: 3 ug/g route of administration: topical experiment type: multiple co-administered:		CALCITRIOL plasma	Homo sapiens population: unhealthy age: Adolescents sex: F+M food status:
764.74 pg*h/mL Clinical Trial https://clinicaltrials.gov/ct2/show/NCT00419666	3 ug/g single, topical dose: 3 ug/g route of administration: topical experiment type: single co-administered:		CALCITRIOL plasma	Homo sapiens population: unhealthy age: Adolescents sex: F+M food status:
549.29 pg*h/mL Clinical Trial https://clinicaltrials.gov/ct2/show/NCT00419666	3 ug/g 2 times / day multiple, topical dose: 3 ug/g route of administration: topical experiment type: multiple co-administered:		CALCITRIOL plasma	Homo sapiens population: unhealthy age: Adolescents sex: F+M food status:
575.12 pg*h/mL Clinical Trial https://clinicaltrials.gov/ct2/show/NCT00419666	3 ug/g single, topical dose: 3 ug/g route of administration: topical experiment type: single co-administered:		CALCITRIOL plasma	Homo sapiens population: unhealthy age: Adolescents sex: F+M food status:

T_1/2

Value	Dose	Co-administered	Analyte	Population
25 h EXPERIMENT https://www.ncbi.nlm.nih.gov/pubmed/12496746	38 μg 3 times / week multiple, oral dose: 38 μg route of administration: Oral experiment type: MULTIPLE co-administered: PACLITAXEL	PACLITAXEL	CALCITRIOL plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN

Sourcing

Vendor/Aggregator	ID	URL
AHH Chemical co.,ltd	NP-1040	http://www.ahhchemical.com/product/NP-1040.html
AbMole Bioscience	M2174	http://www.abmole.com/products/calcitriol.html
Achemo Scientific Limited	AC-16679	http://www.achemo.com/search/?Keyword= 32222-06-3
Achemtek	0101-001973	http://www.achemtek.com/32222-06-3
Alfa Chemistry	AP32222063-C	https://reagents.alfa-chemistry.com/product/1-25-dihydroxyvitamin-d3-cas-32222-06-3-9957.html
Alfa Chemistry	AP32222063-A	https://reagents.alfa-chemistry.com/product/1-25-dihydroxyvitamin-d3-solution-cas-32222-06-3-9955.html
Alfa Chemistry	AP32222063-B	https://reagents.alfa-chemistry.com/product/calcitriol-solution-cas-32222-06-3-9956.html
Alfa Chemistry	32222-06-3	https://www.alfa-chemistry.com/calcitriol-cas-32222-06-3-item-291485.htm
Alsachim	1921	http://www.alsachim.com/product-C2847-glo.bal-view.html
ApexBio Technology	B2141	http://www.apexbt.com/calcitriol.html
Aurora Fine Chemicals LLC	A17.877.497	http://online.aurorafinechemicals.com/info?ID=A17.877.497
Aurora Fine Chemicals LLC	K02.111.135	http://online.aurorafinechemicals.com/info?ID=K02.111.135
Aurum Pharmatech LLC	W-5161	http://www.Aurumpharmatech.com/Product/ProductDetails/W_5161
AvaChem Scientific	2191	http://www.avachem.com/productSearch.asp?2191
BLD Pharm	BD01358017	http://www.bldpharm.com/products/1000873-74-4.html
BioCrick	BCC4950	http://www.biocrick.com/Calcitriol-BCC4950.html
Boerchem	BC208534	http://www.boerchem.com/?product_35283.html
Calbiochem	679101	http://www.emdbiosciences.com/product/679101
Capot Chemical	18818	http://www.capotchem.com/en/18818.htm
Capot Chemical	PubChem18818	http://www.capotchem.com/en/18818.htm
Capot Chemical	19327	http://www.capotchem.com/en/19327.htm
Capot Chemical	PubChem19327	http://www.capotchem.com/en/19327.htm
Chem Scene	CS-0388	http://www.chemscene.com/32222-06-3.html
ChemMol	30104349	http://www.chemmol.com/chemmol/30104349.html
ChemMol	44003293	http://www.chemmol.com/chemmol/44003293.html
ChemMol	49408407	http://www.chemmol.com/chemmol/49408407.html
ChemMol	99070257	http://www.chemmol.com/chemmol/99070257.html
Chemspace	CSSB00020610488	https://chem-space.com/CSSB00020610488
Chiralblock Biosciences	CB11406	http://www.chiralblock.com/products/32222-06-3.html
Clearsynth	CS-O-06153	https://www.clearsynth.com/en/CSO06153.html
EMD Millipore	679101	http://www.emdbiosciences.com/product/679101
Excenen	EX-A4435	https://www.excenen.com/searchresultlist.php?id=EX-A4435
Glentham Life Sciences	GP9482	http://www.glentham.com/products/product/GP9482/
Hello Bio	HB3962	http://www.hellobio.com/luteolin-5897.html
LGC Standards	DRE-A10934950AL-100	https://www.lgcstandards.com/US/en/p/DRE-A10934950AL-100
LGC Standards	DRE-C10934950	https://www.lgcstandards.com/US/en/p/DRE-C10934950
LGC Standards	MM0205.00	https://www.lgcstandards.com/US/en/p/MM0205.00
Lab Network	LN01276594	https://labnetwork.com/frontend-app/p/#!/moleculedetails/LN01276594
Matrix Scientific	144307	https://www.matrixscientific.com/144307.html
MedChem Express	HY-10002	https://www.medchemexpress.com/Calcitriol.html
MuseChem	A000862	https://www.musechem.com/product/A000862.html
OChem	1562	http://www.ocheminc.com/index.php?act=psearch&pid=222C063
Parchem	28433	http://www.parchem.com/chemical-supplier-distributor/Calcitriol-018433.aspx
Selleck Chemicals	S1466	http://www.selleckchem.com/products/Calcitriol-(Rocaltrol).html
Sigma-Aldrich	C0225000_SIAL	https://www.sigmaaldrich.com/catalog/product/sial/c0225000?utm_source=pubchem&utm_campaign=pubchem_2017&utm_medium=referral
Sigma-Aldrich	17936_SIGMA	https://www.sigmaaldrich.com/catalog/product/sigma/17936?utm_source=pubchem&utm_campaign=pubchem_2017&utm_medium=referral
Sigma-Aldrich	D1530_SIGMA	https://www.sigmaaldrich.com/catalog/product/sigma/d1530?utm_source=pubchem&utm_campaign=pubchem_2017&utm_medium=referral
Smolecule	S800501	https://www.smolecule.com/products/s800501
Sun-shine Chemical	Calcitriol	http://sun-shinechem.com/
TCI (Tokyo Chemical Industry)	C3078	http://www.tcichemicals.com/eshop/en/us/commodity/C3078/index.html
Tocris	2551	https://www.tocris.com/products/calcitriol_2551
VladaChem	VL266434-2.5mg	https://www.vladachem.com/product.php?products=32222-06-3
Yuhao Chemical	LT7054	http://www.chemyuhao.com/32222-06-3.html
abcr GmbH	AB465093	http://www.abcr.com/shop/en/AB465093
eNovation Chemicals	D371145	http://www.enovationchem.com/productDetails.asp?productID=D371145
eNovation Chemicals	Y0974280	https://www.enovationchem.com/ProductDetails.asp?ProductID=Y0974280
iChemical	EBD646297	http://www.ichemical.com/products/32222-06-3.html?utm_source=PubChem&utm_medium=website&utm_campaign=product%20catalogs

PubMed

Title	Date	PubMed
Effect of 1,25-dihydroxyvitamin D3 on the female reproductive system in rats.	1992 Aug	1453499
Dose-dependent effects of aluminum on osteocalcin synthesis in osteoblast-like ROS 17/2 cells in culture.	1992 Dec	1476184
Potentiation of lipopolysaccharide-induced tumor necrosis factor-alpha expression by 1,25-dihydroxyvitamin D3.	1992 Dec 1	1450407
EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro.	1992 Dec 15	1472092
A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets.	1992 Sep	1517380
Zinc increases the activity of vitamin D-dependent promoters in osteoblasts.	2000 Apr 29	10777672
Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2.	2000 Jan	10614618
1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms.	2000 Jul	10875257
Regulation of vitamin D-1alpha-hydroxylase and -24-hydroxylase expression by dexamethasone in mouse kidney.	2000 Mar	10694374
Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling.	2001 Dec	11751517
Failure of high doses of calcitriol and hypercalcaemia to induce apoptosis in hyperplastic parathyroid glands of azotaemic rats.	2001 Mar	11239023
1 alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts.	2001 Nov	11679963
Regression of ventral striatum hypometabolism after calcium/calcitriol therapy in paroxysmal kinesigenic choreoathetosis due to idiopathic primary hypoparathyroidism.	2001 Nov	11606688
Hyperphosphatemia modestly retards parathyroid hormone suppression during calcitriol-induced hypercalcemia in normal and azotemic rats.	2002 Dec	12399635
Demonstration of UVB-induced synthesis of 1 alpha,25-dihydroxyvitamin D3 (calcitriol) in human skin by microdialysis.	2003 Apr	12709817
Effects of Seocalcitol (EB1089) on nitrosomethyl urea-induced rat mammary tumors.	2003 Aug	14503802
Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats.	2003 Aug	12846736
9-cis retinoic acid accelerates calcitriol-induced osteocalcin production and promotes degradation of both vitamin D receptor and retinoid X receptor in human osteoblastic cells.	2003 Aug 15	12898515
Comparison of the gene expression profiles of monocytic versus granulocytic lineages of HL-60 leukemia cell differentiation by DNA microarray analysis.	2003 Aug 15	12875902
Vitamin D enhances mitogenesis mediated by keratinocyte growth factor receptor in keratinocytes.	2003 Jun 1	12761878
1alpha,25(OH)2D3 causes a rapid increase in phosphatidylinositol-specific PLC-beta activity via phospholipase A2-dependent production of lysophospholipid.	2003 May	12798493
Vitamin D inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm.	2003 Nov 21	12954644
Previtamin D3 with a trans-fused decalin CD-ring has pronounced genomic activity.	2003 Sep 12	12829710
Unique regulation of SOST, the sclerosteosis gene, by BMPs and steroid hormones in human osteoblasts.	2004 Aug	15268896
Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.	2004 Aug	15264182
Calcitriol-induced prostate-derived factor: autocrine control of prostate cancer cell growth.	2004 Dec 20	15386353
Targacept active conformation search: a new method for predicting the conformation of a ligand bound to its protein target.	2004 Dec 30	15615532
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.	2004 Feb	14966565
Structural determinants for vitamin D receptor response to endocrine and xenobiotic signals.	2004 Jan	14525957
Retinoblastoma protein and CCAAT/enhancer-binding protein beta are required for 1,25-dihydroxyvitamin D3-induced monocytic differentiation of HL60 cells.	2004 Jan 1	14729647
Differential regulation of osteogenic marker gene expression by Wnt-3a in embryonic mesenchymal multipotential progenitor cells.	2004 Jun	15270777
Leptin corrects increased gene expression of renal 25-hydroxyvitamin D3-1 alpha-hydroxylase and -24-hydroxylase in leptin-deficient, ob/ob mice.	2004 Mar	14657008
Improved anemia and reduced erythropoietin need by medical or surgical intervention of secondary hyperparathyroidism in hemodialysis patients.	2004 May	15354979
The functional consequences of cross-talk between the vitamin D receptor and ERK signaling pathways are cell-specific.	2004 Nov 5	15331595
Calcium and calcitriol prophylaxis attenuates posttransplant bone loss.	2004 Oct 27	15502727
Role of uncoupling protein 2 (UCP2) expression and 1alpha, 25-dihydroxyvitamin D3 in modulating adipocyte apoptosis.	2004 Sep	15231722
Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels.	2005 Apr	15781002
Daily or intermittent calcitriol administration during growth hormone therapy in rats with renal failure and advanced secondary hyperparathyroidism.	2005 Apr	15728789
Molecular and functional comparison of 1,25-dihydroxyvitamin D(3) and the novel vitamin D receptor ligand, lithocholic acid, in activating transcription of cytochrome P450 3A4.	2005 Apr 1	15578590
1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.	2005 Feb	15647825
Human bladder as a novel target for vitamin D receptor ligands.	2005 Feb	15572423
Amphiregulin is a novel growth factor involved in normal bone development and in the cellular response to parathyroid hormone stimulation.	2005 Feb 4	15509566
Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo.	2005 Jan 28	15531762
Regulation of the human vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites.	2005 Jan 31	15664452
Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells.	2005 Jun	15671080
Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats.	2005 Mar	15746989
Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients.	2005 Mar	15698453
Regulation of renal calcium receptor gene expression by 1,25-dihydroxyvitamin D3 in genetic hypercalciuric stone-forming rats.	2005 May	15788476
5alpha-dihydrotestosterone inhibits 1alpha,25-dihydroxyvitamin D3-induced expression of CYP24 in human prostate cancer cells.	2005 May 15	15538745
Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.	2005 Sep 1	15754350

Patents

Sample Use Guides

In Vivo Use Guide

Mice: Trans-calcitriol at 1.0, 2.0, and 4.0 mg/kg did not elicit any clinical effects after a single oral dose followed by 14 days of observation.

Route of Administration: Oral

In Vitro Use Guide

Unknown

Substance Class	Chemical Created by `admin` on `Fri Jun 25 20:54:08 UTC 2021` Edited by `admin` on `Fri Jun 25 20:54:08 UTC 2021`
Record UNII	FXC9231JVH
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CALCITRIOL

Official Name

English

CALCITRIOL [WHO-DD]

Common Name

English

CALCITRIOL [MART.]

Common Name

English

VECTICAL

Brand Name

English

CALCITRIOL [VANDF]

Common Name

English

ROCALTROL

Brand Name

English

CALCIJEX

Brand Name

English

CALCITRIOL [USP MONOGRAPH]

Common Name

English

CALCITRIOL [EP MONOGRAPH]

Common Name

English

(1S,3R,5Z,7E)-9,10-SECOCHOLESTA-5,7,10-TRIENE-1,3,25-TRIOL

Common Name

English

CALCITRIOL [USP-RS]

Common Name

English

RO-21-5535

Code

English

CALCITRIOL [JAN]

Common Name

English

RO-215535

Code

English

CALCITRIOL [HSDB]

Common Name

English

CALCITRIOL [ORANGE BOOK]

Common Name

English

CALCITRIOL [INN]

Common Name

English

1,25-HYDROXYLATED VITAMIN D

Common Name

English

1,25-DIHYDROXYVITAMIN D3

Common Name

English

RO 21-5535

Code

English

CALCITRIOL [USAN]

Common Name

English

CALCITRIOL [MI]

Common Name

English

9,10-SECOCHOLESTA-5,7,10(19)-TRIENE-1,3,25-TRIOL, (1.ALPHA.,3.BETA.,5Z,7E)-

Common Name

English

(5Z,7E)-9,10-SECOCHOLESTA-5,7,10(19)-TRIENE-1.ALPHA.,3.BETA.,25-TRIOL

Common Name

English

1,25-DIHYDROXYCHOLECALCIFEROL, (1ALPHA)-

Common Name

English

Classification Tree Code System Code

NDF-RT

N0000006996